SFCM
Seven Fleet Capital Management Portfolio holdings
AUM
$148M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$148M
AUM Growth
–
Holding
85
Top Buys
| 1 | +$62.7M | |
| 2 | +$7.13M | |
| 3 | +$6.02M | |
| 4 |
Revolution Medicines
RVMD
|
+$4.31M |
| 5 |
TERN
Terns Pharmaceuticals
TERN
|
+$3.01M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Monte Rosa Therapeutics
GLUE
$1.61B
| $62.7K | 0.04% |
+4,000
|
|
||
77
Traws Pharma
TRAW
$25.5M
| $55.7K | 0.04% |
+49,260
|
|
||
|
ATXS
78
DELISTED
Astria Therapeutics
ATXS
| $52.4K | 0.04% |
+4,000
|
|
||
79
Edgewise Therapeutics
EWTX
$3.66B
| $49.6K | 0.03% |
+2,000
|
|
||
80
VistaGen Therapeutics
VTGN
$24.6M
| $41.5K | 0.03% |
+62,701
|
|
||
81
Enanta Pharmaceuticals
ENTA
$422M
| $35.8K | 0.02% |
+2,270
|
|
||
82
Cullinan Oncology
CGEM
$993M
| $31.1K | 0.02% |
+3,000
|
|
||
|
GBIO
83
DELISTED
Generation Bio
GBIO
| $30.5K | 0.02% |
+5,376
|
|
||
84
Eledon Pharmaceuticals
ELDN
$301M
| $9.06K | 0.01% |
+6,000
|
|
||
85
Vir Biotechnology
VIR
$1.59B
| $1.21K | ﹤0.01% |
+200
|
|